Your session is about to expire
← Back to Search
Community Health Navigator Program for Chronic Conditions (ENCOMPASS Trial)
N/A
Waitlist Available
Led By Kerry A McBrien, MD, MPH
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Congestive heart failure (at least one instance of a physician billing diagnosis with a relevant ICD-9 code recorded in EMR, or known to health care team)
Poorly controlled diabetes (A1C > 9% on at least one occasion within the past year or labile)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 36 months
Awards & highlights
ENCOMPASS Trial Summary
This trial is testing a patient navigation program that connects people with long-term health conditions to specially trained community health navigators. The navigators help patients get the most out of their health care and connect them to resources. The trial is expanding to primary care settings across Alberta to see if the program can be scaled to a provincial level.
Who is the study for?
This trial is for adults with chronic conditions like heart disease, uncontrolled diabetes or high blood pressure, advanced kidney disease, COPD or asthma, and heart failure. They must have had specific diagnoses confirmed by a doctor's records or known to their health care team. People can't join if they live in long-term care facilities, can't consent to the study themselves, or are excluded at their doctor's discretion.Check my eligibility
What is being tested?
The ENCOMPASS study is testing a Community Health Navigator Program where trained community members help patients navigate the healthcare system. The goal is to see if this program improves healthcare outcomes for people with multiple long-term health issues when implemented across primary care settings in Alberta.See study design
What are the potential side effects?
Since this trial involves a support program rather than medication, there aren't typical drug side effects. However, participants may experience changes in how they interact with the healthcare system and access services.
ENCOMPASS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with congestive heart failure.
Select...
My diabetes has been poorly controlled, with an A1C over 9% in the past year.
Select...
I have been diagnosed with heart disease.
Select...
My kidney function is significantly reduced.
ENCOMPASS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute care service use
Secondary outcome measures
Acute care costs
All-cause mortality
Anxiety symptoms
+22 moreENCOMPASS Trial Design
2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Community health navigator program for six months.
Group II: ControlExperimental Treatment1 Intervention
Waitlist control: six-month waiting period followed by six months of community health navigator program.
Find a Location
Who is running the clinical trial?
University of AlbertaOTHER
888 Previous Clinical Trials
384,862 Total Patients Enrolled
University of CalgaryLead Sponsor
792 Previous Clinical Trials
869,058 Total Patients Enrolled
Kerry A McBrien, MD, MPHPrincipal InvestigatorUniversity of Calgary
3 Previous Clinical Trials
420 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your high blood pressure is not well controlled, with recent readings consistently above 160 mmHg.I have been diagnosed with congestive heart failure.My diabetes has been poorly controlled, with an A1C over 9% in the past year.I have been diagnosed with heart disease.I am unable to understand and give consent for treatment.You live in a long-term care facility.My kidney function is significantly reduced.I have COPD or asthma and have seen a doctor for it at least twice last year.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment of participants still open for this investigation?
"Clinicaltrials.gov suggests that this medical research is currently recruiting participants, with the trial first appearing on January 22nd 2021 and its latest amendment occurring in May 19th 2022."
Answered by AI
What is the upper limit of patients accepted for this research endeavor?
"Affirmative. According to the information on clinicaltrials.gov, this medical trial has been recruiting since it was first posted on January 22nd 2021 and is currently seeking 200 patients from a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger